Creative Financial Statements From 2010 to 2024

CELZ Stock  USD 2.43  0.02  0.82%   
Creative Medical financial statements provide useful quarterly and yearly information to potential Creative Medical Technology investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Creative Medical financial statements helps investors assess Creative Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Creative Medical's valuation are summarized below:
Gross Profit
39.8 K
Market Capitalization
4.3 M
Enterprise Value Revenue
56.0662
Revenue
11 K
Earnings Share
(3.80)
We have found one hundred twenty available fundamental signals for Creative Medical Technology, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Creative Medical Technology prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Enterprise Value is likely to rise to about 3.2 M in 2024, whereas Market Cap is likely to drop slightly above 3.4 M in 2024.

Creative Medical Total Revenue

8,550

Check Creative Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Creative Medical's main balance sheet or income statement drivers, such as Selling General Administrative of 3.2 M, Other Operating Expenses of 5.9 M or Total Operating Expenses of 5.8 M, as well as many indicators such as Price To Sales Ratio of 757, Dividend Yield of 0.0039 or PTB Ratio of 0.66. Creative financial statements analysis is a perfect complement when working with Creative Medical Valuation or Volatility modules.
  
Check out the analysis of Creative Medical Correlation against competitors.

Creative Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets11.3 M10.7 M3.6 M
Slightly volatile
Total Current Liabilities352.8 K371.4 K4.1 M
Pretty Stable
Accounts Payable370.6 K317.3 K405.7 K
Slightly volatile
Common Stock Shares Outstanding1.5 M1.4 M291 K
Slightly volatile
Liabilities And Stockholders Equity11.3 M10.7 M3.6 M
Slightly volatile
Other Stockholder Equity72.9 M69.4 M21.3 M
Slightly volatile
Total Liabilities352.8 K371.4 K4.2 M
Pretty Stable
Total Current Assets10.8 M10.3 M3.4 M
Slightly volatile
Common Stock1.4 K1.4 K135.3 K
Pretty Stable
Cash2.2 M3.5 M2.4 M
Slightly volatile
Cash And Short Term Investments10.5 M10 M3.4 M
Slightly volatile
Short and Long Term Debt Total15.5 K16.3 K257 K
Pretty Stable
Short Term Debt15.5 K16.3 K253.1 K
Pretty Stable
Other Current Liabilities59.1 K62.2 K3.5 M
Pretty Stable
Other Liabilities2.6 K3.7 K2.4 K
Slightly volatile
Non Current Assets Total401.4 K444.3 K261.6 K
Slightly volatile
Long Term Debt78282412.1 K
Slightly volatile
Short and Long Term Debt692 K907 K461.5 K
Slightly volatile
Intangible Assets400 K441 K260.9 K
Slightly volatile
Capital Stock1.4 K1.4 K598.1 K
Slightly volatile
Other Assets0.860.92.6 K
Slightly volatile

Creative Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative3.2 M3.1 M1.2 M
Slightly volatile
Other Operating Expenses5.9 M5.6 M2.1 M
Slightly volatile
Total Operating Expenses5.8 M5.5 MM
Slightly volatile
Interest Expense109.6 K115.4 K634 K
Slightly volatile
Depreciation And Amortization57.6 K94.6 K35.5 K
Slightly volatile
Reconciled Depreciation64 K105.9 K39.8 K
Slightly volatile

Creative Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow8.7 M8.3 M1.9 M
Slightly volatile
End Period Cash Flow3.6 M3.5 M1.8 M
Slightly volatile
Depreciation48.1 K94.6 K34.9 K
Slightly volatile
Dividends Paid3.8 M4.3 M4.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio757721286
Very volatile
Dividend Yield0.00390.00430.0047
Slightly volatile
Days Sales Outstanding11.2911.89201
Slightly volatile
Average Payables525.8 K500.7 K247 K
Slightly volatile
Stock Based Compensation To Revenue7.834.07217.4543
Slightly volatile
Capex To Depreciation2.161.221.8632
Slightly volatile
Inventory Turnover0.520.5463.7876
Slightly volatile
Days Of Inventory On Hand702669166
Slightly volatile
Payables Turnover0.01080.01135.427
Slightly volatile
Sales General And Administrative To Revenue8.078.5103
Slightly volatile
Research And Ddevelopement To Revenue23021963.8406
Slightly volatile
Capex To Revenue5.0610.03.6
Slightly volatile
Cash Per Share6.747.0949252
Pretty Stable
Payout Ratio0.00150.00170.0018
Slightly volatile
Days Payables Outstanding33.8 K32.2 K8.8 K
Slightly volatile
Intangibles To Total Assets0.03910.04120.3514
Pretty Stable
Current Ratio29.0427.6555.1178
Slightly volatile
Receivables Turnover33.3731.7814.7734
Slightly volatile
Graham Number23.6724.918913.3 K
Pretty Stable
Capex Per Share0.07760.081734.5039
Slightly volatile
Average Receivables1.4 K1.4 K3.4 K
Slightly volatile
Revenue Per Share0.00610.006429.1778
Slightly volatile
Interest Debt Per Share17.9418.892.5 K
Slightly volatile
Debt To Assets1.21.2689.2318
Pretty Stable
Operating Cycle702669310
Very volatile
Days Of Payables Outstanding33.8 K32.2 K8.8 K
Slightly volatile
Dividend Payout Ratio0.00150.00170.0018
Slightly volatile
Quick Ratio29.0227.63725.1144
Slightly volatile
Net Income Per E B T1.341.141.261
Slightly volatile
Cash Ratio9.89.33472.5224
Slightly volatile
Days Of Inventory Outstanding702669166
Slightly volatile
Days Of Sales Outstanding11.2911.89201
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.321.161.1976
Slightly volatile
Debt Ratio1.21.2689.2318
Pretty Stable
Price Sales Ratio757721286
Very volatile
Asset Turnover8.0E-48.0E-40.067
Pretty Stable

Creative Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.4 M6.5 MM
Slightly volatile

Creative Fundamental Market Drivers

Cash And Short Term Investments10 M

Creative Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Creative Medical Financial Statements

Creative Medical investors use historical fundamental indicators, such as Creative Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Creative Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-16.3 K-15.5 K
Total RevenueK8.6 K
Cost Of Revenue3.6 K3.4 K
Stock Based Compensation To Revenue 4.07  7.83 
Sales General And Administrative To Revenue 8.50  8.07 
Research And Ddevelopement To Revenue 218.96  229.91 
Capex To Revenue 10.00  5.06 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(624.46)(593.24)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.